ReviewCancers2026
Delayed Lymphatic Reconstruction for Breast Cancer-Related Lymphedema.
Review in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast cancer-related lymphedema (BCRL) is a chronic disease that stems from damage to the lymphatic system due to breast cancer treatment leading to interstitial fluid buildup in the affected extremity. Patients with axillary lymph node dissection in combination with radiation therapy are at the highest risk of developing lymphedema. The mainstay non-surgical treatment involves participation in complete decongestive therapy with certified lymphedema therapists, daily compression garment usage, at-home pump treatments, and diligent skin care. Surgical treatments options can help alleviate symptoms associated with the disease by improving lymphatic drainage and removing fibrofatty tissue. Immediate lymphatic reconstruction (ILR) involves reconstructing cut lymphatics prophylactically at the time of axillary dissection with lymphovenous bypass (LVB) to decrease the risk of developing lymphedema. Delayed reconstruction addresses clinically diagnosed lymphedema and is divided into physiologic and debulking surgical techniques. Physiologic surgeries include lymphovenous bypass and vascularized lymph node transplantation (VLNT) aimed to treat fluid buildup. Debulking surgeries include lymphatic sparing liposuction or direct excision of fibrofatty tissues in the affected extremity to treat excess fibrofatty tissue secondary to lymphedema. This review discusses the pathophysiology of BCRL, diagnosis and staging of the disease, as well as provides an algorithmic overview on delayed lymphatic reconstruction options for BCRL.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.